Deferasirox Tablet, For Suspension
Product Images NDC 69452-160

5 FDA label images from Bionpharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 69452-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Molecularstructure01)

Molecular Structure (Molecularstructure01)
Chemical structure of deferasirox, showing its molecular arrangement with multiple aromatic rings, hydroxyl groups, and nitrogen atoms characteristic of this iron chelator compound.*
FDA Label Image

Figure (Figure001)

Figure (Figure001)
A bar chart illustrating the changes in liver iron content and serum ferritin levels for different doses of Deferasirox (mg/kg/day). The x-axis lists doses of 5, 10, 20, and 30 mg/kg/day with sample sizes, while the y-axes show the change in liver iron content (mg Fe/g dw) on the left and change in serum ferritin (mcg/L) on the right. White bars represent liver iron content changes, and black bars represent serum ferritin changes across the four doses.*
FDA Label Image

125 mg Label (Image0001)

125 mg Label (Image0001)
Deferasirox Tablets for Oral Suspension, 125 mg per tablet, oral tablets to be dispersed in water, orange, or apple juice prior to ingestion. The label includes usage instructions, storage conditions (20°C to 25°C), and a warning to keep out of reach of children. Pack contains 30 tablets. Distributed by Bionpharma Inc., Princeton, NJ. The label also features a barcode and space for serialization.*
FDA Label Image

250 mg Label (Image0002)

250 mg Label (Image0002)
Packaging label for Deferasirox Tablets for Oral Suspension, 250 mg per tablet. The label includes instructions that tablets must be dispersed in water, orange, or apple juice before ingestion and cautions against swallowing whole. It features storage instructions, dosage guidance to see the package insert, and a 30-tablet count. Distributed by Bionpharma Inc., Princeton, NJ. NDC 69452-160-13.*
FDA Label Image

500 mg Label (Image0003)

500 mg Label (Image0003)
Label for Deferasirox Tablets for Oral Suspension, 500 mg per tablet, distributed by Bionpharma Inc. The label includes instructions not to chew or swallow whole tablets, which must be dispersed in water, orange, or apple juice before ingestion. The package contains 30 tablets and provides storage guidelines and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.